To include your compound in the COVID-19 Resource Center, submit it here.

Recombinant Bet v 1 update

Data from the 3-year, double-blind, placebo-controlled, 4-arm, European DV08.01 trial in 150 patients showed

Read the full 141 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE